Purpose: To prospectively evaluate a gadolinium-based collagen-targeting contrast agent, EP-3533, for in vivo magnetic resonance (MR) imaging of myocardial fibrosis in a mouse model of healed myocardial infarction (MI).
Materials And Methods: All procedures were performed in accordance with protocols approved by the animal care and use committee. MI was induced in eight mice by means of occlusion of the left anterior descending coronary artery followed by reperfusion. Four MR examinations were performed in each animal: one examination before, one examination 1 day after, and two examinations 6 weeks after the MI. For the latter two examinations, electrocardiographically gated inversion-recovery gradient-echo MR images were acquired before and serially (every 5 minutes) after the intravenous injection of either gadopentetate dimeglumine or EP-3533. The image enhancement kinetic properties of the postinfarction scar, normal myocardium, and blood were compared.
Results: Dynamic T1-weighted MR imaging revealed the washout time constants for EP-3533 to be significantly longer than those for gadopentetate dimeglumine in regions of postinfarction scarring (mean, 194.8 minutes +/-116.8 [standard deviation] vs 25.5 minutes +/- 4.2; P < .05) and in normal myocardium (mean, 45.4 minutes +/- 16.7 vs 25.1 minutes +/- 9.7; P < .05). Findings on postmortem histologic sections stained for collagen correlated well with EP-3533-enhanced areas seen on inversion-recovery MR images. Fifty minutes after EP-3533 injection, the postinfarction scar tissue samples, as compared with the normal myocardium, had a twofold higher concentration of gadolinium.
Conclusion: Use of the gadolinium-based collagen-targeting contrast agent, EP-3533, enabled in vivo molecular MR imaging of fibrosis in a mouse model of healed postinfarction myocardial scarring.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410958 | PMC |
| http://dx.doi.org/10.1148/radiol.2473070975 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A robust collagen-targeting MRI peptide contrast agent for imaging of hepatic fibrosis.
Chem Commun (Camb)
October 2024
State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, P. R. China.
Article Synopsis
- Researchers developed a new MRI peptide contrast agent called Gd-ICTP.
- This agent is highly selective for type I collagen, which is important for detecting liver fibrosis.
- Gd-ICTP allows for accurate and non-invasive imaging, improving the diagnosis of hepatic fibrosis.
Collagen denaturation in post-run Achilles tendons and Achilles tendinopathy: In vivo mechanophysiology and magnetic resonance imaging.
Sci Adv
October 2024
Department of Radiology, Guangdong Provincial Engineering Research Center of Molecular Imaging, Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong 519000, China.
Article Synopsis
- Achilles tendinopathy is commonly linked to overuse, but the exact biological mechanisms behind it are still not fully understood.
- This study found that running does not mechanically unfold collagen in rat Achilles tendons but causes collagen to break down through a process called proteolysis, contributing to tendon damage.
- The research also shows that running triggers inflammation and leads to ongoing degradation of collagen, which may help understand Achilles tendinopathy better and improve diagnostic imaging techniques.
Retraction: A robust collagen-targeting MRI peptide contrast agent for imaging of hepatic fibrosis.
Chem Commun (Camb)
October 2024
State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, 730000, P. R. China.
Article Synopsis
- - The article discusses the retraction of a previous publication that proposed a new MRI contrast agent aimed at improving imaging of liver fibrosis using collagen-targeting peptides.
- - The retraction was prompted by concerns regarding the validity of the methodology and results presented in the original research.
- - Authors and publishers emphasize the importance of scientific integrity and transparency in the research community.
A robust collagen-targeting MRI peptide contrast agent for imaging of hepatic fibrosis.
Chem Commun (Camb)
May 2023
State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, P. R. China.
We herein report the construction of a robust MRI peptide contrast agent Gd-ICTP with superior selectivity for type I collagen, enabling the accurate and non-invasive detection of hepatic fibrosis .
View Article and Find Full Text PDFSide-chain modification of collagen-targeting peptide prevents dye aggregation for improved molecular imaging of arthritic joints.
J Photochem Photobiol A Chem
February 2022
Optical Radiology Laboratory, Department of Radiology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Near-infrared (NIR) dye-peptide conjugates are widely used for tissue-targeted molecular fluorescence imaging of pathophysiologic conditions. However, the significant contribution of both dye and peptide to the net mass of these bioconjugates implies that small changes in either component could alter their photophysical and biological properties. Here, we synthesized and conjugated a type I collagen targeted peptide, RRANAALKAGELYKCILY, to either a hydrophobic (LS1000) or hydrophilic (LS1006) NIR fluorescent dye.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!